Nonsteroidal Mineralocorticoid Receptor Antagonist Eliciting Cardiorenal Protection Is a New Option for Patients with Chronic Kidney Disease

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) protect cardiorenal function by robust anti-inflammatory and antifibrotic functions beyond classical functions of maintaining fluid and electrolyte homeostasis. The application of traditional steroidal MRAs to chronic kidney disease (CKD) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenyu, Yu, Shengqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900468/
https://www.ncbi.nlm.nih.gov/pubmed/36756081
http://dx.doi.org/10.1159/000528066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900468/
https://www.ncbi.nlm.nih.gov/pubmed/36756081
http://dx.doi.org/10.1159/000528066

Ejemplares similares